Previous close | 1.0800 |
Open | 1.2000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 42.50 |
Expiry date | 2026-01-16 |
Day's range | 1.0700 - 1.2000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Olema's (OLMA) shares surge on the successful development of its lead candidate in metastatic breast cancer indication.
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates are expected drive the stock in the future quarters.
Key Insights Institutions' substantial holdings in Pfizer implies that they have significant influence over the...